Professor Lee Seung-hoon of Seoul National University Hospital has revisited SBS <Discovery of Knowledge>. Having studied obesity treatments for a long time, he was asked whether it is safe to take Mounjaro for the rest of one's life. Previously, Professor Chang Hyung-woo of Seoul National University Bundang Hospital, well-known as a physician who takes Mounjaro himself, appeared on <Discovery of Knowledge> and expressed his determination to stay on Mounjaro for life. While noting that it is a "personal choice," Professor Lee pointed out that the monitoring period for patients in clinical trials for both Wegovy and Mounjaro has not exceeded five years. What does this mean? Let us hear Professor Lee Seung-hoon's explanation regarding the "truth" behind pancreatitis and vision loss, which are frequently cited as major side effects of GLP-1 receptor agonist obesity drugs.
(Produced by SBS Digital News | Planning: Kim Yong-tae, Host: Jeong Yu-mi, Writer: 박정례, Editing: Kim Hye-joo, Filming: Kim Sang-yoon, Park Woo-jin, CG: Cho Eun-sol, Direction: Cho Do-hye)
※
Copying, redistribution, and unauthorized use in AI training are strictly prohibited.